Currently Enrolling Studies

Coronavirus (COVID-19) Vaccine

There is currently no vaccine to protect against COVID-19, nor any specific antiviral treatment. The best way to prevent the infection is to avoid being exposed to the virus until a vaccine is available. This study will evaluate the safety and efficacy of an investigational COVID-19 vaccine.

*Compensation for time and travel may be available to those who qualify.

Intranasal Migraine Relief (One Year Study)

The purpose of this research study is to examine an investigational nasal spray for the treatment of an acute migraine headache. The study drug is a CGRP receptor blocker administered through a nasal spray. The study will last approximately one year long with 17 visits to our office.

Intranasal Migraine Relief

The purpose of this research study is to examine an investigational nasal spray for the treatment of one acute migraine headache.

Coronavirus

In anticipation for future coronavirus vaccine studies we will need the help of our community of volunteers. Please visit our website to submit your interest in being part of future Covid-19 vaccine studies. Currently there are no available research studies for Covid-19, however, we are actively tracking a list of companies with plans to conduct vaccine studies this year. With your help, BHCCR could be a part of the development of a potentially life saving vaccine.

Migraine & Depression

This study will evaluate the efficacy of a study drug in adult patients with migraines and Major Depression. The aim of the study is to lower the number of your migraines per month.

Knee Pain

Baptist Health Center for Clinical Research is currently enrolling individuals between the ages of 40 – 80 for a research study of a new study drug aimed at reversing the degenerative changes in your cartilage and bone. The study drug would be administered through a single injection in the knee with the most pain. The study would last approximately up to 56 weeks with 9 visits to our office.

Migraine Treatment Study

Migraines are a disease that cause disabling headaches. Baptist Health Center for Clinical Research is conducting a study to determine if the study drug is effective as a treatment of an ongoing or acute headache. The study drug is given in a single dose via infusion at our clinic.

*Compensation for time and travel may be available to those who qualify.